Skip to content

Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal Hypoglycemia

Dextrose Boluses Versus Dextrose Infusions by Burettes in Prevention of Hypoglycemia Among Preterms Admitted at Mulago Hospital: An Open Label Randomized Clinical Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01688674
Enrollment
140
Registered
2012-09-20
Start date
2012-02-29
Completion date
2012-04-30
Last updated
2012-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Once a Preterm Developed Hypoglycemia, no More Blood Glucose Was Measured During the Study Period.

Brief summary

NULL HYPOTHESIS • There is no difference in the incidence of hypoglycemia among preterms receiving either two hourly 10% dextrose boluses or 10% dextrose infusion by burettes during the 72 hours of admission in Special Care Unit- Mulago Hospital. ALTERNATE HYPOTHESIS • Use of two hourly 10% dextrose boluses increases the incidence of hypoglycemia by 30% compared to 10% dextrose infusion by burettes among preterms admitted to Special Care Unit in the first 72 hours of admission.

Interventions

Sponsors

Makerere University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 24 Hours
Healthy volunteers
Yes

Inclusion criteria

\- SELECTION CRITERIA Inclusion criteria * Preterms whose care givers/ mothers gave informed consent * Preterms whose age was \< 24 hours of life * Preterms with birth weight ≥1kg * Preterms with random blood sugar ≥ 2.6 mmol/l at admission into SCU.

Exclusion criteria

* Absence of a biological mother or abandoned baby * Presence of gross congenital abnormalities. * Very sick (Apgar score ≤ 5 at 5 minutes

Design outcomes

Primary

MeasureTime frame
Incidence proportion of hypoglycemia3months

Secondary

MeasureTime frame
survival measured as a proportion3months

Countries

Uganda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026